Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",27438,101,1.51 [1.13-2.03],0.0056229678824388
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",28009,143,1.09 [0.85-1.39],0.498200523937966
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27754,1000,1.18 [1.07-1.29],0.0005969623760016
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Candidiasis,28044,306,1.17 [0.99-1.38],0.0669521412032987
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,27247,2757,1.15 [1.09-1.22],1.0116737620406174e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27506,2079,1.18 [1.11-1.26],4.555089756863511e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,27831,995,1.16 [1.05-1.27],0.0022758065254658
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,27955,41,0.96 [0.61-1.52],0.870296960451321
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26777,641,1.25 [1.11-1.41],0.0001529151408055
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25882,614,1.36 [1.21-1.53],4.012751870316624e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,26135,172,1.18 [0.94-1.47],0.1518894261447547
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,20910,1209,1.25 [1.15-1.36],3.128459448299512e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,25897,285,1.42 [1.19-1.68],7.247382006122087e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27993,1157,1.13 [1.04-1.23],0.0052458735841339
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Mycoses,28105,367,1.17 [1.01-1.37],0.0416670725621306
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27359,605,1.25 [1.11-1.41],0.0002644494388483
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,28041,704,1.27 [1.14-1.42],2.6685698664847567e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26981,145,1.09 [0.85-1.39],0.4977299461812315
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,28145,32,1.71 [1.02-2.88],0.0418933255814593
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27957,620,1.26 [1.12-1.41],0.000157397478097
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27986,72,1.24 [0.88-1.75],0.2164577335268382
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,28050,172,1.23 [0.98-1.54],0.0681919707321556
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",28036,158,1.23 [0.98-1.56],0.0801795537699478
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,27086,332,1.31 [1.12-1.55],0.0009406930229686
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,27000,246,1.08 [0.90-1.30],0.4221495728970731
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,26917,81,1.25 [0.91-1.74],0.1736206845424833
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,28116,52,1.74 [1.17-2.60],0.00640573224742
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,28082,131,1.69 [1.31-2.18],6.555969042521357e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral warts,27996,45,1.90 [1.23-2.94],0.0036190397191246
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],28001,50,1.26 [0.83-1.92],0.2738728190935751
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm,27855,318,1.08 [0.91-1.27],0.3821994066473562
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,28052,76,1.11 [0.80-1.56],0.5249300435155019
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,28033,80,0.91 [0.66-1.26],0.5799771931223104
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,12556,45,1.20 [0.76-1.89],0.4332565565116494
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27947,1190,1.04 [0.95-1.13],0.3880565446473719
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of meninges,28134,49,0.81 [0.54-1.23],0.3259457618440413
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,28110,50,0.94 [0.62-1.42],0.7748756052138619
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,28124,95,1.01 [0.75-1.36],0.9413623628204496
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of ovary,15528,101,1.08 [0.81-1.44],0.6201919812685122
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,28138,281,0.95 [0.80-1.14],0.5873552286058918
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Caecum,28134,207,0.95 [0.78-1.17],0.6347776570776591
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",28076,59,0.71 [0.49-1.02],0.0658506690283666
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Descending colon,28137,175,0.96 [0.77-1.19],0.6901255210018573
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Rectum,28100,291,0.94 [0.79-1.12],0.4725582267170117
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,28068,544,1.10 [0.97-1.25],0.1533369430656447
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,28138,317,0.91 [0.77-1.07],0.2569322421556829
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Carcinoma in situ of breast,13363,90,0.92 [0.68-1.26],0.607305855086367
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",13411,102,0.95 [0.71-1.27],0.7299231401754344
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",24330,31,0.83 [0.49-1.40],0.4796106861731949
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",24338,39,1.05 [0.65-1.69],0.8331558637487477
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",28103,112,0.96 [0.73-1.27],0.7762844782720275
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Haemangioma, any site",28103,110,0.96 [0.72-1.27],0.7714156632566902
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Leiomyoma of uterus,14888,417,0.94 [0.82-1.08],0.3907445975391697
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Lung cancer and mesothelioma,20931,178,1.19 [0.95-1.50],0.133369234035017
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Lymphoid leukaemia,24329,30,0.68 [0.41-1.12],0.13287549867361
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24447,148,1.35 [1.05-1.73],0.0170655337449518
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",24383,84,1.11 [0.80-1.54],0.5294010151140848
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",13466,84,1.10 [0.80-1.51],0.5567529472552938
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",24350,51,1.78 [1.18-2.69],0.0059328672698068
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",24368,69,1.23 [0.86-1.76],0.2618609425227222
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",24371,72,1.24 [0.87-1.76],0.2320228484763402
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",13437,55,0.79 [0.54-1.16],0.2283940617289743
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",24355,56,1.06 [0.72-1.56],0.7756971616177866
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",11330,413,1.03 [0.88-1.19],0.730230055607908
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",24390,91,1.04 [0.76-1.43],0.7837292414727004
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",24356,57,0.98 [0.66-1.44],0.9027212620526884
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,24363,64,1.10 [0.75-1.59],0.6316892995184585
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanocytic naevi,27907,218,1.32 [1.08-1.62],0.0070061296279006
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanocytic naevi of trunk,28095,96,1.39 [1.02-1.89],0.0349181101603218
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanoma in situ,24313,49,1.11 [0.72-1.70],0.6439933980566157
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",24359,60,0.90 [0.62-1.31],0.5817727172278968
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",24421,122,1.10 [0.84-1.44],0.4916774557463746
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",24418,119,1.10 [0.83-1.45],0.5108529004697919
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",24367,68,1.00 [0.70-1.43],0.9901141375447904
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Other benign neoplasms of skin,27960,145,0.86 [0.68-1.09],0.221953216623477
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",24962,663,0.99 [0.88-1.11],0.8326996415954411
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",24995,696,1.00 [0.89-1.12],0.996242304893701
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27873,288,1.11 [0.93-1.32],0.2335740318650315
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,26713,57,1.56 [1.06-2.31],0.024966130158203
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,27655,70,1.18 [0.83-1.67],0.3604469578714258
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,27341,2251,1.20 [1.13-1.28],9.925809644726272e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,26945,25,1.21 [0.67-2.19],0.5362098116121392
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,27792,35,1.11 [0.68-1.82],0.6779323567851574
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27704,1048,1.23 [1.13-1.35],5.900208099870611e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27704,1048,1.23 [1.13-1.35],5.900208099870611e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,26714,58,2.58 [1.77-3.76],8.656583475975482e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27857,937,1.24 [1.13-1.37],9.198211854420922e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,27867,110,1.02 [0.77-1.34],0.9111517273688085
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27638,53,1.34 [0.90-2.01],0.1540373920538089
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,27628,43,1.03 [0.66-1.62],0.8889396923032464
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,27948,191,1.27 [1.03-1.58],0.0267607160111463
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,28066,70,1.49 [1.05-2.10],0.0249270839242637
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",27916,159,1.34 [1.06-1.69],0.0143740938191908
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,26994,74,1.00 [0.71-1.41],0.9903853462717728
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,24211,213,1.40 [1.14-1.72],0.0010967612506292
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,26200,126,0.92 [0.71-1.20],0.5527563147563932
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,26211,137,0.86 [0.67-1.11],0.239784037369263
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,24037,39,1.55 [0.96-2.49],0.072251190623053
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,26152,71,1.28 [0.90-1.82],0.1636932357570615
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,25798,149,0.99 [0.78-1.26],0.9508735377103636
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",27997,172,1.12 [0.89-1.40],0.3391275655686586
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,27872,47,1.42 [0.92-2.20],0.1126547632313475
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,27863,38,1.01 [0.62-1.63],0.9727341332976652
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,27729,1648,1.09 [1.02-1.18],0.0164835494051291
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,25215,1598,1.09 [1.01-1.18],0.0191032981381066
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",24040,42,1.23 [0.78-1.94],0.3693805032892741
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",26444,56,1.09 [0.74-1.61],0.660750890035297
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,24184,186,1.16 [0.93-1.44],0.1817315424497745
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,24062,64,1.75 [1.21-2.54],0.0031755029128718
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,26419,2421,0.93 [0.88-0.99],0.0185249719051014
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,24113,115,1.19 [0.90-1.56],0.2294994831111355
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,24385,387,1.21 [1.04-1.41],0.0121786165771028
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,28042,275,1.12 [0.94-1.33],0.2178298813444757
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,27881,114,1.29 [0.98-1.71],0.0660694143530431
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,24096,98,0.94 [0.70-1.27],0.7055709180751736
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",24038,40,1.59 [1.00-2.52],0.0520472083848636
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27713,1325,1.01 [0.94-1.10],0.730520027621048
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,24126,128,1.25 [0.96-1.62],0.1009100707327879
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,24160,162,1.57 [1.24-1.98],0.0001403504332183
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",24391,393,0.96 [0.83-1.12],0.6203927324162726
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,24057,59,1.40 [0.95-2.05],0.0849378078064587
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,27874,107,1.26 [0.94-1.67],0.1173166238736049
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,24298,300,1.28 [1.08-1.52],0.0047389341345009
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,24295,297,1.06 [0.89-1.26],0.5010726456591033
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,25708,59,1.33 [0.91-1.95],0.1448790801453549
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,27454,3456,1.01 [0.96-1.06],0.8343278271299285
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,26424,36,1.13 [0.70-1.83],0.6119786234407334
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,26447,59,1.07 [0.73-1.56],0.7324511259575075
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,27962,1952,0.94 [0.88-1.00],0.0590717661722321
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",27966,1949,0.94 [0.88-1.00],0.0653140890795301
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,26426,38,1.00 [0.63-1.58],0.9847475358287944
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,27816,1252,1.05 [0.96-1.14],0.2641989401003177
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",24900,902,1.23 [1.11-1.36],3.963263099813551e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,28135,133,1.69 [1.32-2.17],4.10277428381591e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,27859,34,0.87 [0.53-1.44],0.5970313856685204
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,26652,88,1.43 [1.05-1.96],0.0245350415078336
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,26683,119,1.05 [0.81-1.38],0.7058777943504704
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",24128,130,1.39 [1.08-1.80],0.0115687132809758
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26326,120,1.76 [1.35-2.30],2.645540102966732e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1731,71,1.27 [0.89-1.81],0.187036207992702
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1839,194,1.58 [1.28-1.95],1.918085107301712e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,26246,40,1.40 [0.89-2.21],0.1487748457307925
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1697,37,2.29 [1.41-3.72],0.0008345551908258
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27722,1516,0.96 [0.89-1.03],0.2356281665435461
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,27899,74,1.29 [0.92-1.82],0.1400709581055127
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,25926,277,1.12 [0.95-1.34],0.1849455878754921
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,24412,414,1.25 [1.08-1.45],0.0022549753197732
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",28057,179,1.11 [0.89-1.38],0.3567554035947883
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),27409,57,1.56 [1.06-2.31],0.0258629024488937
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Angina pectoris,26857,808,1.04 [0.94-1.16],0.4251747976885726
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,27456,104,1.29 [0.96-1.73],0.0880216194423811
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,27382,30,1.41 [0.83-2.40],0.2005262919024959
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",27456,104,1.22 [0.91-1.63],0.1790277828504534
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,20106,953,1.24 [1.13-1.37],8.943686909672715e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,AV-block,25625,186,1.17 [0.94-1.46],0.1586401484187761
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",28112,263,0.97 [0.81-1.16],0.732914128118466
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Cardiac arrest,19266,113,1.02 [0.77-1.34],0.911084776639895
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25575,136,1.37 [1.06-1.76],0.0164044173520127
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",25519,80,1.50 [1.07-2.09],0.0173546572409644
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,28147,21,0.80 [0.42-1.51],0.4866367473813238
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Conduction disorders,25976,537,1.17 [1.03-1.33],0.014626194707067
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,27412,1374,1.03 [0.95-1.11],0.5007277089276192
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,26188,6122,1.00 [0.96-1.04],0.9666193929708726
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26968,188,1.17 [0.94-1.45],0.1548550599971483
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Endocarditis,25483,44,1.05 [0.67-1.63],0.8360366288488146
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",28027,522,1.20 [1.05-1.36],0.0055379296112873
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertension,26776,4991,0.97 [0.93-1.01],0.1070160928214829
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",26791,5006,0.97 [0.93-1.01],0.1274491301479018
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27976,58,1.43 [0.97-2.12],0.0697234197453621
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",21872,87,1.41 [1.03-1.93],0.0325589054810375
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,21845,60,2.41 [1.66-3.50],3.596363012624723e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypotension,28044,703,1.12 [1.00-1.25],0.0430655022927765
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,27609,65,1.06 [0.74-1.53],0.7564704661311952
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27578,1529,1.01 [0.94-1.09],0.7525799436418175
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27913,310,1.11 [0.94-1.31],0.229863439918398
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,25633,194,1.15 [0.93-1.42],0.1976315358255024
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27881,603,0.93 [0.83-1.05],0.2431329484676997
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26539,490,0.97 [0.85-1.11],0.6809660662829666
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",28089,121,1.00 [0.76-1.31],0.9921644088886252
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",28130,207,1.17 [0.95-1.43],0.1409695831366966
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Oesophageal varices,26821,41,1.22 [0.76-1.95],0.4017083160114814
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other aneurysm,27403,51,1.53 [1.01-2.31],0.0442558665415283
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,25681,242,1.27 [1.05-1.53],0.0152886759544073
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,27416,64,1.30 [0.90-1.88],0.1660316395052101
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27497,145,1.49 [1.16-1.90],0.0014811852746181
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,25568,129,1.16 [0.89-1.50],0.2711197696238854
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other disorders of veins,26854,74,1.44 [1.02-2.03],0.0372961458240107
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,26829,49,1.62 [1.07-2.47],0.0238226731512601
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,27357,39,0.68 [0.44-1.06],0.0897998261114923
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,26871,91,1.05 [0.77-1.43],0.7667812059119877
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,26029,590,1.25 [1.11-1.41],0.0003446169935669
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,27384,43,1.49 [0.95-2.35],0.0809355696241753
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27691,339,1.32 [1.12-1.54],0.0007882911922052
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27696,157,1.46 [1.15-1.84],0.0015280217776113
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",27557,239,1.08 [0.89-1.31],0.437494309339948
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19409,256,1.37 [1.14-1.65],0.0007756602213316
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27530,204,1.23 [1.00-1.52],0.046763530692488
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),27041,261,1.22 [1.01-1.47],0.0344008233805301
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27879,340,1.23 [1.05-1.45],0.0100879216588202
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,28104,330,1.22 [1.04-1.44],0.0166991314247951
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,25616,177,1.33 [1.07-1.67],0.01193405240463
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27692,153,1.50 [1.19-1.90],0.0007119162253738
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,27437,119,1.21 [0.92-1.58],0.1756624126988059
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27906,362,1.08 [0.93-1.27],0.3030644567370488
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27880,397,1.08 [0.93-1.25],0.3161606485284056
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,27585,53,0.85 [0.57-1.26],0.4160613016763016
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,27406,55,1.37 [0.91-2.05],0.1293575273409465
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27748,145,0.89 [0.69-1.13],0.3277413324208929
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27461,183,0.83 [0.67-1.03],0.0967494685829744
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Varicose veins,27103,323,1.31 [1.11-1.55],0.001212890008843
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,27361,48,1.70 [1.11-2.61],0.0147323157466866
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27972,539,1.20 [1.06-1.37],0.0047069868216134
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27985,376,0.87 [0.75-1.01],0.0734137038356557
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",25112,1439,1.05 [0.97-1.14],0.2007066357008362
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Any mental disorder,27383,3710,1.04 [0.99-1.10],0.0860181183184484
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27920,446,0.92 [0.80-1.06],0.2286370484242378
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",25351,1678,1.10 [1.02-1.18],0.0087003107201197
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23764,91,1.32 [0.97-1.80],0.0785979989712205
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Smoking dependency,27604,1534,1.05 [0.98-1.14],0.1790245294677982
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",25451,1778,1.03 [0.96-1.11],0.3799093361824031
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Vascular dementia,28028,20,1.59 [0.82-3.09],0.1731934153113073
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Alzheimer disease,28147,65,1.35 [0.93-1.95],0.1111878332867075
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Bell's palsy,26459,76,1.10 [0.79-1.55],0.559984650918359
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26875,492,1.00 [0.88-1.15],0.948671574324937
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral cysts,27788,210,1.03 [0.84-1.26],0.761674677144216
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,28063,233,1.03 [0.85-1.25],0.7813223969869528
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,28002,24,1.19 [0.65-2.19],0.5708823084130654
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,28132,52,1.08 [0.72-1.64],0.6989246842643819
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",27639,61,1.04 [0.71-1.51],0.8547179263500695
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Epilepsy,26554,265,1.47 [1.23-1.76],3.322265479426183e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27658,1369,1.10 [1.01-1.19],0.020470807873285
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,28118,275,0.91 [0.76-1.09],0.294115613393759
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27619,1677,1.06 [0.98-1.14],0.1232540983877539
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Generalized epilepsy,27767,54,1.51 [1.01-2.26],0.0447192279241151
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Hemiplegia,27999,169,1.11 [0.89-1.40],0.3520358994816677
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Hydrocephalus,27625,47,0.98 [0.64-1.50],0.9205620916603536
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,28123,65,1.61 [1.12-2.32],0.0101002599035854
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,26464,81,0.95 [0.68-1.31],0.7412940115668865
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,26469,86,1.12 [0.82-1.54],0.4821817990459263
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Memory loss,27994,75,1.22 [0.87-1.72],0.2496338401706057
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Migraine,26722,433,1.07 [0.93-1.23],0.3404427010983711
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",28055,385,1.09 [0.94-1.26],0.2773349183435614
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Motor neuron disease,20527,100,1.05 [0.78-1.42],0.7417842659789802
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27950,145,0.98 [0.77-1.26],0.8815811995726445
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27536,1153,1.04 [0.96-1.14],0.344901302394845
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Neurological diseases,26709,3139,1.07 [1.01-1.13],0.0123210620261085
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,28054,76,1.25 [0.89-1.76],0.2009929060654808
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26773,390,1.04 [0.90-1.21],0.5886154854993367
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",28078,239,1.09 [0.90-1.32],0.3873119134677442
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23487,311,1.20 [1.01-1.42],0.0381195156906637
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,27639,61,1.33 [0.91-1.95],0.1378420648336247
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,27693,115,1.18 [0.90-1.56],0.2238846280826894
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,27935,92,0.92 [0.67-1.25],0.5788142884220828
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,26477,94,1.13 [0.84-1.53],0.4238024316317014
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other headache syndromes,26350,61,0.92 [0.64-1.33],0.6648849825554053
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other neurological diseases,28024,446,1.11 [0.97-1.28],0.1303555416591262
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other sleep disorders,26881,592,1.04 [0.93-1.18],0.4711527148198321
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Parkinson's disease,28134,161,0.92 [0.73-1.16],0.4782178400189615
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,27643,65,0.85 [0.59-1.21],0.3688402286023297
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Restless leg syndrome,28146,48,1.01 [0.66-1.55],0.9563161138506302
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Sleep apnoea,27901,513,1.01 [0.89-1.14],0.9222350988412026
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,27876,37,0.80 [0.49-1.29],0.3547134874182975
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,28132,127,1.20 [0.93-1.57],0.1662627896943672
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,26415,32,0.92 [0.55-1.54],0.7496655162899417
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,28147,66,1.30 [0.90-1.87],0.1661472180946311
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),28016,19,1.58 [0.80-3.12],0.1889781756563309
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,27661,43,1.03 [0.66-1.63],0.8902341486723899
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,27790,220,1.02 [0.84-1.25],0.8322392764941116
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,28057,197,1.55 [1.26-1.90],3.1417457163958525e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,27390,38,1.25 [0.78-2.03],0.3554253827317004
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,27428,76,1.00 [0.72-1.41],0.9818471488090628
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",28054,30,1.27 [0.74-2.16],0.3831967053745144
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,27942,62,0.90 [0.62-1.30],0.5747719822102735
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1704,44,2.33 [1.51-3.62],0.0001520559614844
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2014,87,1.26 [0.92-1.73],0.1456586704935422
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,27697,79,0.88 [0.64-1.22],0.4547975000342863
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,28018,636,1.29 [1.15-1.45],1.8469441786785505e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27837,485,1.01 [0.88-1.15],0.929399523870335
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27488,136,1.15 [0.89-1.47],0.2862000763189352
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",28051,481,1.04 [0.91-1.19],0.5960769627704023
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,28134,54,0.94 [0.63-1.40],0.7600772374753669
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,27975,405,1.06 [0.91-1.22],0.465754520177389
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",28102,222,1.35 [1.10-1.64],0.0032654432313069
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,28081,128,1.07 [0.82-1.39],0.6182476698024311
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,27369,17,0.96 [0.47-1.98],0.920644147947298
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,27381,29,0.65 [0.39-1.07],0.0901891679384357
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,27385,33,0.92 [0.55-1.53],0.7442426137665227
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,28098,385,1.14 [0.98-1.33],0.0807195422991189
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,27815,102,1.25 [0.94-1.68],0.1265061673327471
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,27592,22,1.62 [0.86-3.06],0.1369536252932929
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,27953,73,1.49 [1.06-2.11],0.0230315515865047
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,28029,149,1.35 [1.06-1.72],0.0146348916327073
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,27733,163,1.04 [0.82-1.31],0.7684229669180056
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,28030,77,1.13 [0.81-1.58],0.4680358571420043
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27967,254,1.15 [0.95-1.38],0.1481096789410481
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,27738,120,1.44 [1.11-1.88],0.0068104403594878
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,27425,1076,1.04 [0.95-1.13],0.4180772623814714
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,28002,122,1.30 [0.99-1.69],0.057526102989477
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,28121,115,1.15 [0.87-1.51],0.3307330219446053
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27622,270,0.97 [0.81-1.16],0.749666895939036
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,27917,37,1.88 [1.15-3.07],0.0119615864571021
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,28117,37,1.06 [0.65-1.71],0.8280966813135939
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,27392,40,0.83 [0.52-1.31],0.4162520377278594
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27471,119,0.87 [0.67-1.14],0.326875752497262
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,27451,69,1.55 [1.08-2.21],0.0161221054320706
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,27631,61,1.07 [0.73-1.56],0.7259093567647854
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",27433,51,1.10 [0.73-1.67],0.6397166080011416
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,27769,56,1.11 [0.74-1.65],0.6150931946266945
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",27803,90,1.08 [0.79-1.48],0.6207743315188141
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,27446,94,1.20 [0.88-1.62],0.2438896254011167
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,27509,127,1.12 [0.86-1.47],0.3862872834219245
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,27418,36,1.66 [1.02-2.71],0.0431093402416151
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,27189,840,1.12 [1.01-1.24],0.0308977023509657
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,27401,49,0.82 [0.54-1.24],0.3536289881200291
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27929,311,1.25 [1.05-1.47],0.0098355459892071
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,27656,38,1.93 [1.20-3.11],0.0065075850984075
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),27748,130,1.36 [1.05-1.76],0.0185264615603918
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,27954,63,1.19 [0.83-1.72],0.3409737574791664
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,28105,97,0.88 [0.66-1.19],0.4191579477391389
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,28023,140,1.10 [0.86-1.42],0.4317412011474604
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,27945,54,0.97 [0.65-1.45],0.8839434089151716
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,27944,53,1.15 [0.77-1.73],0.494101813133382
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,28057,543,1.15 [1.01-1.30],0.0347141933525586
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,27851,337,1.25 [1.06-1.46],0.0077174004274
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,27613,99,1.29 [0.96-1.74],0.0868803614628492
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,27596,82,1.02 [0.73-1.41],0.9245093318574112
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Acute pharyngitis,27859,83,1.06 [0.77-1.46],0.712911171359621
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,28013,237,0.99 [0.82-1.20],0.9189269831788416
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,27841,65,0.95 [0.66-1.36],0.7698466624667054
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,All influenza,26810,78,1.59 [1.14-2.21],0.0058572766789301
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),26808,76,1.60 [1.15-2.23],0.0058171251686594
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),20881,128,1.19 [0.91-1.54],0.1993747451275905
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Allergic rhinitis,27990,315,0.92 [0.78-1.08],0.308019909095902
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",22397,1790,1.07 [0.99-1.14],0.0747774837667673
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",22514,1761,1.07 [1.00-1.14],0.0680921126806427
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),27853,94,1.38 [1.02-1.87],0.0344600326406963
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",26787,55,1.81 [1.22-2.67],0.0028986192003973
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Bronchiectasis,25050,183,1.52 [1.22-1.90],0.0001576990344625
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",24908,41,1.10 [0.69-1.74],0.693700411635269
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,27263,2396,1.09 [1.03-1.16],0.0043547434649988
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26649,69,1.39 [0.97-1.99],0.0693194663422734
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,26751,171,1.03 [0.82-1.29],0.8119326266907874
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",28039,730,1.21 [1.08-1.35],0.0007123496116185
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,26709,129,1.13 [0.87-1.47],0.3447201245150392
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,26197,4327,1.08 [1.03-1.13],0.0010611950707852
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26961,381,1.14 [0.98-1.32],0.0938764855148491
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Early onset COPD,27822,513,1.17 [1.03-1.34],0.0195225421284601
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Emphysema,25057,190,1.55 [1.24-1.94],0.0001522360544513
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26892,115,1.64 [1.24-2.16],0.0004726946685936
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27959,1227,1.19 [1.10-1.30],4.3149059291869045e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,26918,141,1.48 [1.15-1.90],0.0020279466848312
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Later onset COPD,26690,217,1.34 [1.09-1.64],0.0047877713953348
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,28138,157,1.46 [1.15-1.85],0.0016514293038613
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Nasal polyp,26695,115,1.00 [0.76-1.32],0.984810686042075
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27932,622,1.26 [1.12-1.42],0.0001035682007811
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,27972,1264,1.19 [1.09-1.29],4.415594275113775e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27479,899,1.07 [0.97-1.18],0.1738646093922444
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other pleural conditions,26742,34,1.19 [0.71-1.99],0.5169809494172157
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,28092,203,1.46 [1.19-1.79],0.0003397476126768
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,28068,865,1.24 [1.13-1.38],1.866662856247956e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pleural effusion,27306,598,1.23 [1.09-1.39],0.0006753121814583
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pleural plaque,26766,58,1.27 [0.86-1.88],0.2382219074382481
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27750,1018,1.21 [1.11-1.33],4.543968072540647e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,28119,138,1.63 [1.26-2.09],0.0001489130476263
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pneumothorax,26769,61,1.48 [1.01-2.17],0.042314879376849
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pollen allergy,28110,269,0.93 [0.78-1.11],0.4192904034194846
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pulmonary oedema,27928,39,1.35 [0.85-2.15],0.2067953653043898
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,20790,37,1.64 [1.00-2.68],0.0482600842508929
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27912,602,1.29 [1.14-1.45],3.754133021167156e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26895,315,0.92 [0.78-1.09],0.3235797925955052
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Viral pneumonia,26927,195,1.13 [0.92-1.40],0.2431900266957383
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",27877,169,1.09 [0.87-1.36],0.4546133536189581
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16279,102,1.18 [0.88-1.58],0.2624926644931536
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21564,66,0.91 [0.64-1.30],0.6043498362356134
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute appendicitis,27946,152,1.02 [0.80-1.30],0.8873740243104508
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute gastritis,22520,74,0.94 [0.67-1.33],0.7309984267940601
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,26530,165,0.91 [0.72-1.14],0.4184627298617296
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute peritonitis,27704,73,1.43 [1.01-2.02],0.0424904248659812
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,27354,82,1.07 [0.77-1.48],0.6837200971364019
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Barrett oesophagus,22808,362,1.11 [0.95-1.30],0.1989366345815132
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",26422,57,1.14 [0.77-1.69],0.5040649127025877
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",27735,57,1.14 [0.77-1.68],0.5106110754236695
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Cholecystitis,26549,184,1.05 [0.84-1.30],0.6782431618001932
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Cholelithiasis,27285,920,1.06 [0.96-1.17],0.2448288988554224
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Chronic gastritis,22709,263,1.20 [1.00-1.44],0.053057429546116
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,26408,43,0.84 [0.54-1.32],0.4515117283515615
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",27999,81,1.80 [1.31-2.49],0.0003328260077672
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Coeliac disease,26698,121,2.38 [1.82-3.10],1.8117454731077447e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Collagenous colitis,26557,61,1.10 [0.75-1.60],0.6334800240507658
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27958,214,0.93 [0.76-1.14],0.4910973276489107
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Constipation,27922,1196,1.09 [1.00-1.19],0.0387290491138816
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Crohn disease,26591,95,1.30 [0.96-1.76],0.093681507098954
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27797,67,1.35 [0.94-1.94],0.1052321141757929
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26588,92,1.35 [0.99-1.84],0.0615162325130334
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Dental caries,27293,263,0.94 [0.79-1.13],0.5226297815550764
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,26038,1856,1.07 [1.00-1.14],0.0614795806949794
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of appendix,27989,195,0.97 [0.79-1.20],0.8101804107070842
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of liver,28023,751,1.04 [0.93-1.16],0.4914379128725203
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",26412,3966,1.08 [1.03-1.13],0.001564361368497
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27654,624,1.02 [0.90-1.14],0.7714415338744725
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,28066,435,1.03 [0.90-1.19],0.6523283703351382
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27164,134,0.91 [0.71-1.17],0.4761947306466303
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,26997,70,1.11 [0.78-1.57],0.5732633440840129
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27867,1290,1.08 [0.99-1.17],0.071487496547307
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of tongue,27011,123,0.80 [0.61-1.03],0.0815787379377155
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27620,1255,1.05 [0.96-1.14],0.26981155805049
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,23970,2472,0.97 [0.91-1.03],0.321056486102753
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,22591,145,1.02 [0.80-1.31],0.8525830470134095
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",28075,114,0.89 [0.67-1.16],0.3838125264506807
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,28010,84,0.96 [0.70-1.33],0.8067747387139291
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,27375,103,1.76 [1.32-2.35],0.0001128801532014
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,21685,187,0.93 [0.75-1.15],0.5038158907940701
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,22964,518,1.00 [0.88-1.14],0.9966567836662882
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastric ulcer,22736,290,1.08 [0.91-1.28],0.3824863135957941
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,24738,2292,1.06 [0.99-1.12],0.0874220670684337
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,22864,418,1.14 [0.99-1.32],0.0719383822248104
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,23019,8234,1.03 [1.00-1.07],0.04005044858754
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,GI-bleeding,27615,1038,1.02 [0.93-1.12],0.6023334836619025
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,27090,60,1.42 [0.97-2.08],0.0742650773557873
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,22444,1321,1.04 [0.96-1.13],0.3202957454732593
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",27324,52,1.08 [0.72-1.62],0.707442787270373
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Hernia,26974,2792,1.06 [1.00-1.12],0.0348609770733655
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Impacted teeth,28020,78,0.96 [0.69-1.35],0.833158896852306
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Impaction of intestines,21532,34,1.27 [0.76-2.11],0.3579825910364149
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Inguinal hernia,24875,693,1.09 [0.97-1.22],0.1647809923832095
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",24262,80,1.13 [0.80-1.59],0.4872992982441138
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,21575,77,1.58 [1.12-2.21],0.0082851988373748
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26718,141,2.29 [1.79-2.94],4.282003145730971e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,22078,580,1.20 [1.06-1.36],0.0030121089197326
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,28121,391,0.92 [0.80-1.07],0.2743790410741119
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,27211,715,1.06 [0.95-1.19],0.2738851376856959
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27402,906,1.06 [0.96-1.16],0.2815797172316747
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22600,154,0.99 [0.78-1.26],0.9454733168706831
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oesophagitis,22939,493,1.10 [0.96-1.26],0.1696193574870885
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,28104,134,1.02 [0.79-1.33],0.8540196693657888
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,24232,50,0.77 [0.51-1.15],0.1973222556577645
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,22817,1319,1.08 [0.99-1.17],0.0767037986059022
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26567,202,1.08 [0.87-1.32],0.4914313635125313
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,26529,164,0.92 [0.73-1.15],0.442645524114554
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,23027,1529,1.05 [0.97-1.13],0.1982299937188038
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,26481,4983,1.04 [0.99-1.08],0.0924564370019313
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,27004,199,1.04 [0.84-1.29],0.6951638782526377
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of liver,27878,606,1.02 [0.90-1.15],0.7556822453639296
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,22995,549,1.14 [1.00-1.30],0.042967670249889
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,26450,85,1.16 [0.84-1.60],0.3579148409135205
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,28009,378,1.00 [0.86-1.16],0.9515988782722378
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,23238,792,1.08 [0.97-1.20],0.1519030884506296
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27628,1051,1.03 [0.94-1.13],0.545248698516686
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27220,190,1.08 [0.87-1.33],0.4914276059718973
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,22743,1245,1.07 [0.99-1.17],0.1004626865803062
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),24261,1815,1.16 [1.08-1.24],3.107283162057681e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,27358,86,1.57 [1.14-2.15],0.0052673036025309
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,27288,792,1.07 [0.96-1.19],0.1982787033053763
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21733,235,1.10 [0.91-1.34],0.3226824661347308
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27994,98,1.05 [0.78-1.42],0.7472422670231282
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21852,354,1.17 [1.00-1.37],0.0507943700162573
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26714,137,0.89 [0.69-1.14],0.3397396569840987
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,28137,59,0.88 [0.60-1.29],0.5217453400800586
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,27045,130,0.95 [0.74-1.23],0.712329209173723
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Toxic colitis,26528,32,1.08 [0.64-1.82],0.7638296266282079
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22630,184,1.17 [0.94-1.46],0.1699019259724619
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,26645,149,1.01 [0.79-1.29],0.913934212322154
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26625,129,1.02 [0.78-1.32],0.8855439841540659
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Umbilical hernia,24464,282,1.02 [0.86-1.22],0.8017810883635338
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,21602,104,1.22 [0.91-1.63],0.1818619957110899
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ventral hernia,24411,229,1.07 [0.88-1.31],0.4755673902456411
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Volvulus,21560,62,1.02 [0.70-1.49],0.90154961702445
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,28090,162,1.09 [0.86-1.38],0.4680208878520095
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,27870,75,1.23 [0.87-1.74],0.2335734080917492
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,26647,150,0.86 [0.67-1.09],0.1999096983381607
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27517,559,1.09 [0.96-1.23],0.196798217278463
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",27159,201,1.00 [0.81-1.23],0.9912343989890776
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,26678,181,1.14 [0.91-1.42],0.2462835893959251
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,27878,232,1.07 [0.88-1.30],0.4934527818227451
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,28046,400,1.09 [0.94-1.26],0.2480473934808963
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,27694,48,1.47 [0.96-2.25],0.0794515790815759
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26668,2622,1.05 [0.99-1.11],0.1265823100519753
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27689,454,0.96 [0.84-1.10],0.5401638379999005
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27560,325,0.96 [0.81-1.13],0.6085705784578979
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27754,796,1.06 [0.95-1.17],0.2848123984553402
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",28136,48,0.64 [0.43-0.94],0.0246877671711961
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,26551,54,1.68 [1.13-2.49],0.0104758975181355
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27276,41,0.80 [0.51-1.25],0.320540490527352
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,27871,225,1.10 [0.91-1.34],0.3327054177225603
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26792,295,1.22 [1.02-1.45],0.0271211782676572
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,26534,37,1.28 [0.78-2.08],0.3249804771611447
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,28061,69,1.01 [0.71-1.44],0.9510288201738544
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,27094,136,1.32 [1.03-1.71],0.0305185239407001
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27954,159,1.05 [0.83-1.33],0.6688732296845101
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27679,33,1.60 [0.96-2.66],0.0730866133051242
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,26550,53,1.10 [0.73-1.66],0.6455264171256139
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27616,1119,1.09 [1.00-1.19],0.048686331480907
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26823,326,1.20 [1.02-1.41],0.0309702804181722
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,26538,41,1.16 [0.73-1.84],0.523816211567697
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,28062,267,0.99 [0.83-1.19],0.9178636583329306
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,27709,63,0.74 [0.52-1.05],0.0932078949012543
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,28014,219,1.10 [0.90-1.35],0.3313422998637836
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,28114,186,1.09 [0.88-1.36],0.4216462994976349
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,26621,124,0.85 [0.66-1.11],0.2328841374878599
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26688,191,0.86 [0.69-1.06],0.1594861298268497
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,28104,176,1.09 [0.87-1.36],0.4781177759317193
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",26628,131,1.29 [1.00-1.66],0.0487198410675251
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,28113,121,1.08 [0.83-1.41],0.5745421193914333
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,24723,139,0.89 [0.70-1.15],0.379594923114795
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,26290,4738,1.02 [0.98-1.07],0.27934568910402
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,24902,3350,1.06 [1.01-1.11],0.0312171683926901
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,24682,98,0.88 [0.66-1.18],0.3853640298778035
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,25282,160,0.87 [0.69-1.09],0.2308970513425621
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,25282,160,0.95 [0.76-1.20],0.664150416756873
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,27918,113,0.81 [0.62-1.05],0.1127769541710218
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",25168,46,0.95 [0.62-1.46],0.8151574017744894
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,22317,765,1.04 [0.93-1.16],0.4820125462088412
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",28086,128,1.02 [0.78-1.32],0.8900730543043964
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,25422,300,1.00 [0.85-1.18],0.993345749587048
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,24636,6368,1.01 [0.97-1.04],0.7594530681189753
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,26754,106,1.25 [0.94-1.67],0.1199991008875212
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,24703,119,1.03 [0.79-1.35],0.8171139474634389
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,25202,618,1.05 [0.93-1.18],0.4594245159213512
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,27251,2129,0.97 [0.91-1.04],0.4159866752485482
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24815,231,0.99 [0.81-1.20],0.9140028158379933
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,24867,283,1.09 [0.91-1.29],0.3479350020430122
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,24735,151,1.07 [0.84-1.37],0.5653066693921853
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,27629,36,0.74 [0.46-1.18],0.2079281640208757
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,22893,1341,1.04 [0.96-1.12],0.3930451148016101
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,21956,404,0.90 [0.78-1.04],0.1624728046726581
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",28096,395,0.91 [0.78-1.05],0.1963847417237481
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21622,70,0.76 [0.54-1.08],0.1258738120978769
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),21909,357,1.11 [0.95-1.30],0.1865441820699399
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24921,337,0.90 [0.77-1.06],0.1980915866739848
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,22333,781,1.00 [0.90-1.11],0.9925941258435628
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,25152,30,1.75 [1.02-3.00],0.041637595347205
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25685,563,1.03 [0.91-1.16],0.6662153660771708
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,25406,284,1.06 [0.89-1.26],0.5063513866837122
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,22280,728,1.00 [0.90-1.12],0.997037062117198
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,24672,88,1.23 [0.90-1.68],0.2008740882567749
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",24645,61,1.15 [0.79-1.68],0.45846851870458
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,26708,60,1.13 [0.78-1.65],0.5171912520682808
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27808,1160,1.18 [1.08-1.29],0.0001691676725174
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,27308,660,1.27 [1.13-1.43],4.11816518237896e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",28036,346,1.08 [0.92-1.26],0.3383012999807131
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,23356,1804,1.09 [1.02-1.17],0.0137721903885519
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,21634,82,1.00 [0.72-1.38],0.9768472417482512
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,24664,80,1.34 [0.96-1.86],0.0841600998826082
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,21580,28,1.69 [0.96-2.98],0.0691902942873018
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21668,116,1.13 [0.86-1.48],0.3978970454292296
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,26876,228,0.89 [0.73-1.07],0.2106936618760162
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,26893,245,1.17 [0.97-1.42],0.0971099263716473
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,28105,87,1.31 [0.95-1.80],0.0956695929125352
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",26720,1598,0.99 [0.92-1.06],0.6863736922171388
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,24709,125,1.18 [0.91-1.54],0.217605400604796
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21672,120,1.23 [0.94-1.61],0.1298606519811154
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25767,645,0.93 [0.83-1.04],0.1918305912589047
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,23632,2080,1.03 [0.97-1.10],0.3023917192729977
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,27651,58,0.99 [0.68-1.46],0.9787339775414116
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,28120,72,1.24 [0.88-1.77],0.2235807075841486
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,24668,84,0.94 [0.68-1.29],0.6843067915818881
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25704,1120,1.06 [0.97-1.16],0.2036453881407895
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,24655,71,0.90 [0.63-1.27],0.5358594132279377
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,22686,1134,1.03 [0.94-1.12],0.5321440444785527
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,26747,99,0.87 [0.65-1.16],0.342123293973925
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,24654,70,1.10 [0.78-1.57],0.5808917082189962
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,25236,114,0.72 [0.55-0.93],0.0137598801819367
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24997,413,1.11 [0.96-1.28],0.1521998955219251
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27805,212,1.26 [1.03-1.54],0.0251079450994394
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,25597,475,1.11 [0.97-1.27],0.1244685916002827
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,28045,326,1.12 [0.95-1.31],0.1858622759602333
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,28129,39,1.88 [1.17-3.01],0.0089487333153837
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24792,208,1.01 [0.82-1.24],0.9423932656900164
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22618,609,1.07 [0.95-1.21],0.2531033712688206
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,25092,508,1.06 [0.93-1.21],0.3724696667286981
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],24759,175,0.90 [0.72-1.12],0.3395211937151682
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",21588,36,0.86 [0.53-1.39],0.54104647739431
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,23343,1791,1.01 [0.94-1.09],0.7259420492930877
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,22012,460,1.05 [0.92-1.21],0.4848935203230559
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,27680,87,1.28 [0.93-1.75],0.1315240768799661
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",28070,52,1.62 [1.07-2.44],0.022758002345399
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",26511,29,1.15 [0.67-1.99],0.6095895970706343
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,21626,74,1.23 [0.87-1.74],0.2421560318700397
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,25214,92,1.05 [0.77-1.42],0.7721594771902472
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,21902,350,1.09 [0.93-1.28],0.2807562866118184
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24861,277,1.01 [0.85-1.21],0.8821059770379615
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,25337,215,1.02 [0.83-1.24],0.87919209947299
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,25231,109,1.10 [0.83-1.46],0.5105018450693537
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,23860,47,0.81 [0.53-1.23],0.3168552786507799
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",28132,42,1.81 [1.15-2.86],0.0103996070636597
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,25205,621,0.91 [0.81-1.02],0.1186438677293923
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],27683,90,1.38 [1.02-1.88],0.0387295176506922
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,27047,2463,1.01 [0.96-1.08],0.6580849178099977
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",24695,111,1.09 [0.83-1.45],0.5300800915300248
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25485,363,1.02 [0.88-1.19],0.7946731851027182
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,26741,184,0.83 [0.67-1.03],0.0912472329723038
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,25278,156,0.98 [0.77-1.23],0.8516658972589879
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,26193,1071,0.96 [0.88-1.05],0.4187480716487086
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25836,714,0.93 [0.84-1.04],0.2190064520105735
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],24629,45,1.44 [0.93-2.22],0.1033793344606235
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27735,142,1.15 [0.90-1.46],0.2770186685873338
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24742,158,1.10 [0.87-1.40],0.4110950726249666
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,24644,60,1.40 [0.96-2.04],0.080889131915606
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),21589,37,0.81 [0.50-1.30],0.3792708599307638
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,27583,875,1.26 [1.14-1.39],7.049932920042597e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11442,75,0.90 [0.65-1.26],0.5451765539986209
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,15198,77,1.08 [0.78-1.51],0.6412290100021976
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27846,329,1.05 [0.89-1.24],0.5383338616326667
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,27579,62,0.89 [0.61-1.29],0.5266450389398863
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,27406,698,1.59 [1.42-1.78],2.8040853186618253e-16
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,27953,32,1.95 [1.16-3.27],0.011538832437783
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,27968,188,1.09 [0.88-1.35],0.4424097135661877
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Cystitis,25884,161,1.14 [0.90-1.43],0.2826840309223364
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Dialysis,26767,59,2.35 [1.61-3.43],9.636855519116532e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,12162,1157,1.03 [0.94-1.12],0.5413349338132778
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15329,208,0.99 [0.81-1.21],0.9001204487284741
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Endometriosis,11507,140,0.98 [0.77-1.25],0.8627138063273839
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",11762,395,0.88 [0.76-1.02],0.0796435546901241
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11800,433,0.95 [0.83-1.09],0.4830291211702723
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23751,4362,1.09 [1.04-1.14],0.0003406941805043
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,27991,70,2.18 [1.55-3.08],9.43791359031121e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hydrocele,11094,89,1.06 [0.77-1.45],0.7288299173742983
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,26623,237,1.14 [0.94-1.39],0.1763531606209023
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,11770,765,1.05 [0.94-1.17],0.3834615226349039
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15182,244,0.94 [0.78-1.13],0.5062574553622878
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),11110,105,1.23 [0.92-1.65],0.1560294148928276
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Irregular menses,15194,129,0.76 [0.60-0.97],0.0306010540735439
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,11670,303,0.91 [0.77-1.07],0.2525987094892834
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,25792,69,1.38 [0.97-1.98],0.0741220134802509
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,12807,1440,1.02 [0.94-1.10],0.6259826739079821
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,11053,48,0.85 [0.56-1.29],0.4430441955756452
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11468,101,1.14 [0.85-1.53],0.3659180853550603
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",28135,38,0.88 [0.55-1.41],0.5897249786386127
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",28142,48,0.82 [0.54-1.25],0.3601967793110742
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,27262,1539,1.10 [1.02-1.18],0.0173447926271243
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,26207,484,1.07 [0.93-1.22],0.3363493192195657
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,15190,69,0.72 [0.51-1.01],0.0589071634348694
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,28096,316,1.15 [0.97-1.36],0.0967931957764778
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,11163,158,1.09 [0.86-1.38],0.4680712912733652
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,11125,120,0.88 [0.68-1.16],0.3673039854285216
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,11083,78,1.28 [0.91-1.79],0.1536640517733231
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,28108,53,0.75 [0.50-1.11],0.145207240760174
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26837,1114,1.13 [1.03-1.23],0.0074144366548117
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,15064,126,0.89 [0.69-1.14],0.3479442947917401
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11455,88,1.18 [0.87-1.61],0.2911948185767556
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11600,233,1.02 [0.84-1.23],0.8360704339353662
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11428,61,0.94 [0.64-1.37],0.7413369070749019
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11474,107,1.02 [0.77-1.36],0.8680932301181297
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26658,272,1.11 [0.92-1.32],0.2709295130419978
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,27893,113,1.15 [0.87-1.53],0.3146710694544753
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11555,188,1.07 [0.87-1.33],0.5211312731989035
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11450,83,0.96 [0.70-1.33],0.816099000410334
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11806,439,0.98 [0.85-1.12],0.7535108357072071
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,11436,69,1.20 [0.84-1.70],0.3165906650640734
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11747,380,1.08 [0.93-1.25],0.3143292520348446
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,27969,48,1.55 [1.01-2.38],0.0425591082378774
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",11116,111,0.78 [0.60-1.03],0.0767673572804742
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27940,1554,1.28 [1.19-1.38],1.1421109437315435e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",26531,145,1.15 [0.90-1.46],0.2662896255552736
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,26785,77,1.82 [1.30-2.55],0.0004707146697509
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27587,70,1.21 [0.85-1.73],0.2853245474829414
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,25893,170,0.99 [0.79-1.24],0.9330331067534684
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27909,392,1.05 [0.91-1.22],0.5142149861684371
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11472,105,0.86 [0.65-1.14],0.3067126382263248
